Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in Lab Invest Retrieve available abstracts of 6 articles: HTML format

Single Articles

December 2022
1. HU QQ, Wen ZF, Huang QT, Li Q, et al
   CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion.
   Lab Invest. 2022;102:1377-1388.
   PubMed     Abstract available
   
   
   September 2022
2. JAKSA R, Karolova J, Svaton M, Kazantsev D, et al
   Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
   Lab Invest. 2022;102:957-965.
   PubMed     Abstract available
   
   
   
3. JAKSA R, Karolova J, Svaton M, Kazantsev D, et al
   Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
   Lab Invest. 2022;102:957-965.
   PubMed     Abstract available
   
   
   
4. XU X, Shobuike T, Shiraki M, Kamohara A, et al
   Leukemia/lymphoma-related factor (LRF) or osteoclast zinc finger protein (OCZF) overexpression promotes osteoclast survival by increasing Bcl-xl mRNA: A novel regulatory mechanism mediated by the RNA binding protein SAM68.
   Lab Invest. 2022;102:1000-1010.
   PubMed     Abstract available
   
   
   July 2022
5. HU QQ, Wen ZF, Huang QT, Li Q, et al
   CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion.
   Lab Invest. 2022 Jul 18. pii: 10.1038/s41374-022-00824.
   PubMed     Abstract available
   
   
   April 2022
6. XU X, Shobuike T, Shiraki M, Kamohara A, et al
   Leukemia/lymphoma-related factor (LRF) or osteoclast zinc finger protein (OCZF) overexpression promotes osteoclast survival by increasing Bcl-xl mRNA: A novel regulatory mechanism mediated by the RNA binding protein SAM68.
   Lab Invest. 2022 Apr 26. pii: 10.1038/s41374-022-00792.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: